Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) |  Cites / Doc. (2years) |
Ref. / Doc. (2018) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Perspectives in Medicinal Chemistry | journal | 1.113 Q1 | 17 | 0 | 5 | 0 | 35 | 5 | 10.50 | 0.00 |  |
| 2 | Nanotechnology, Science and Applications | journal | 1.755 Q1 | 35 | 3 | 25 | 213 | 290 | 25 | 8.53 | 71.00 | |
| 3 | Theranostics | journal | 2.176 Q1 | 158 | 425 | 655 | 25196 | 5581 | 640 | 8.17 | 59.28 |  |
| 4 | Journal for ImmunoTherapy of Cancer | journal | 3.337 Q1 | 117 | 150 | 269 | 6491 | 1982 | 241 | 8.01 | 43.27 |  |
| 5 | Particle and Fibre Toxicology | journal | 1.661 Q1 | 119 | 47 | 153 | 3157 | 1082 | 149 | 7.03 | 67.17 | |
| 6 | Acta Pharmaceutica Sinica B | journal | 1.893 Q1 | 99 | 96 | 229 | 5554 | 1658 | 216 | 5.91 | 57.85 |  |
| 7 | Cancer Nanotechnology | journal | 1.220 Q1 | 36 | 11 | 24 | 564 | 133 | 21 | 5.81 | 51.27 |  |
| 8 | Results in Pharma Sciences | journal | 0.578 Q2 | 19 | 0 | 4 | 0 | 18 | 4 | 5.67 | 0.00 |  |
| 9 | Journal of Nanobiotechnology | journal | 1.255 Q1 | 109 | 100 | 260 | 6229 | 1525 | 257 | 5.57 | 62.29 | |
| 10 | Molecular Therapy - Nucleic Acids | journal | 2.011 Q1 | 95 | 213 | 329 | 11528 | 1934 | 321 | 5.46 | 54.12 | |
| 11 | Journal of Pharmaceutical Analysis | journal | 0.763 Q1 | 51 | 56 | 161 | 2037 | 698 | 161 | 5.06 | 36.38 | |
| 12 | Vaccines | journal | 2.136 Q1 | 85 | 81 | 150 | 6256 | 848 | 145 | 4.94 | 77.23 |  |
| 13 | Emerging Contaminants | journal | 1.701 Q1 | 36 | 5 | 51 | 267 | 270 | 49 | 4.93 | 53.40 | |
| 14 | EPMA Journal | journal | 1.085 Q1 | 52 | 34 | 86 | 2395 | 393 | 83 | 4.87 | 70.44 | |
| 15 | Pharmaceutics | journal | 1.091 Q1 | 106 | 288 | 129 | 19050 | 636 | 124 | 4.84 | 66.15 | |
| 16 | Emerging Microbes and Infections | journal | 2.117 Q1 | 94 | 206 | 249 | 8902 | 1150 | 188 | 4.75 | 43.21 | |
| 17 | International Journal of Nanomedicine | journal | 1.098 Q1 | 179 | 605 | 1696 | 30652 | 8610 | 1683 | 4.74 | 50.66 | |
| 18 | npj Vaccines | journal | 2.527 Q1 | 47 | 51 | 50 | 2652 | 236 | 48 | 4.72 | 52.00 | |
| 19 | PLoS Neglected Tropical Diseases | journal | 2.669 Q1 | 163 | 854 | 2584 | 41239 | 12295 | 2529 | 4.62 | 48.29 | |
| 20 | International Journal of Pharmaceutics | journal | 1.135 Q1 | 258 | 788 | 2619 | 41229 | 12053 | 2589 | 4.53 | 52.32 | |
| 21 | Journal of Food and Drug Analysis | journal | 1.160 Q1 | 79 | 150 | 314 | 6460 | 1506 | 312 | 4.53 | 43.07 |  |
| 22 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.781 Q2 | 92 | 161 | 595 | 7720 | 2400 | 595 | 4.36 | 47.95 | |
| 23 | Altex | journal | 0.893 Q2 | 64 | 46 | 117 | 133 | 456 | 102 | 4.31 | 2.89 |  |
| 24 | PPAR Research | journal | 1.605 Q1 | 59 | 19 | 79 | 1024 | 374 | 77 | 4.27 | 53.89 | |
| 25 | Drug Delivery | journal | 0.937 Q1 | 95 | 180 | 681 | 8530 | 2834 | 681 | 4.23 | 47.39 | |
| 26 | International Journal of Neuropsychopharmacology | journal | 1.846 Q1 | 125 | 138 | 406 | 7958 | 1857 | 395 | 4.21 | 57.67 | |
| 27 | Nanotheranostics | journal | 32 | 32 | 32 | 1822 | 134 | 32 | 4.19 | 56.94 | | |
| 28 | npj Systems Biology and Applications | journal | 35 | 41 | 64 | 2533 | 251 | 63 | 4.18 | 61.78 | | |
| 29 | Expert Review of Vaccines | journal | 1.603 Q1 | 105 | 102 | 358 | 8283 | 1412 | 327 | 4.12 | 81.21 | |
| 30 | Marine Drugs | journal | 0.855 Q2 | 159 | 518 | 1006 | 27743 | 4860 | 1003 | 4.00 | 53.56 | |
| 31 | Pharmacognosy Reviews (discontinued) | journal | 0.767 Q2 | 68 | 30 | 66 | 2310 | 261 | 65 | 4.00 | 77.00 |  |
| 32 | Protein and Cell | journal | 2.280 Q1 | 94 | 103 | 313 | 5758 | 1411 | 235 | 3.98 | 55.90 | |
| 33 | Pharmaceuticals | journal | 1.209 Q1 | 87 | 137 | 216 | 11991 | 872 | 203 | 3.92 | 87.53 | |
| 34 | Saudi Pharmaceutical Journal | journal | 0.670 Q1 | 76 | 163 | 360 | 6375 | 1344 | 353 | 3.92 | 39.11 | |
| 35 | Therapeutic Advances in Neurological Disorders | journal | 1.521 Q1 | 68 | 80 | 111 | 4715 | 476 | 102 | 3.89 | 58.94 | |
| 36 | Frontiers in Pharmacology | journal | 1.256 Q1 | 154 | 1497 | 1757 | 97013 | 7210 | 1686 | 3.87 | 64.80 | |
| 37 | Toxins | journal | 1.029 Q1 | 116 | 542 | 1121 | 34242 | 4358 | 1085 | 3.87 | 63.18 | |
| 38 | Biomedicine and Pharmacotherapy | journal | 0.931 Q2 | 149 | 1763 | 2601 | 91881 | 9902 | 2592 | 3.85 | 52.12 |  |
| 39 | Artificial Cells, Nanomedicine and Biotechnology | journal | 0.582 Q2 | 86 | 552 | 511 | 24774 | 1844 | 509 | 3.81 | 44.88 | |
| 40 | European Journal of Pharmaceutical Sciences | journal | 0.882 Q1 | 163 | 491 | 1097 | 23608 | 4231 | 1083 | 3.78 | 48.08 | |
| 41 | Applied and Translational Genomics | journal | 1.231 Q1 | 25 | 0 | 72 | 0 | 210 | 59 | 3.72 | 0.00 | |
| 42 | Life Sciences | journal | 1.017 Q1 | 191 | 649 | 1202 | 36375 | 4240 | 1194 | 3.63 | 56.05 | |
| 43 | Clinical and Experimental Vaccine Research | journal | 1.022 Q1 | 19 | 18 | 21 | 847 | 75 | 19 | 3.57 | 47.06 |  |
| 44 | Clinical and Translational Science | journal | 0.955 Q1 | 60 | 77 | 235 | 2521 | 602 | 210 | 3.46 | 32.74 | |
| 45 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.997 Q1 | 64 | 90 | 154 | 4065 | 547 | 152 | 3.45 | 45.17 | |
| 46 | Journal of Experimental Pharmacology | journal | 0.937 Q2 | 23 | 9 | 21 | 630 | 72 | 21 | 3.35 | 70.00 | |
| 47 | BioImpacts | journal | 0.752 Q1 | 47 | 32 | 92 | 1655 | 330 | 87 | 3.27 | 51.72 |  |
| 48 | F1000Research | journal | 1.235 Q1 | 105 | 793 | 1677 | 38678 | 5083 | 1595 | 3.25 | 48.77 | |
| 49 | Drug Design, Development and Therapy | journal | 0.986 Q1 | 94 | 378 | 1213 | 16732 | 4161 | 1188 | 3.23 | 44.26 | |
| 50 | Pharmacogenomics and Personalized Medicine | journal | 0.965 Q2 | 37 | 23 | 61 | 1180 | 199 | 58 | 3.22 | 51.30 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data